FDA Approves Emrosi for Rosacea in Adults
Phase 3 trials show significant reduction in total lesion count versus Oracea and placebo
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Phase 3 trials show significant reduction in total lesion count versus Oracea and placebo
Only registered members have full access to PracticeUpdate content.